Patients who communicate early about side effects are often easier to support than patients who wait until nausea, constipation, fatigue, or poor intake has already disrupted treatment
GLP-1s are not just another diabetes medication
Husain M, Birkenfeld AL, Donskmark M et al (2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
When Is Microdosing Appropriate
There is just no standard of care. Emily Hilliard, a spokesperson for the Department of Health and Human Services, told KFF Health News that compounded drugs should only be used in patients whose medical needs cannot be met by an FDA-approved drug. Hilliard said the agency urges consumers to be vigilant and know the source of their medicine. Understanding the Risks While weight loss drugs have helped millions of people lose weight, theyre not without risk, the data shows
Why Tirzepatide is Different: The Power of GIP + GLP-1 When someone has PCOS, hormonal imbalances may work against weight loss goals